APO Research
Talk to an analyst

APO RESEARCH · REPORT

EPA & DHA Omega-3

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global EPA & DHA Omega-3 Industry Growth and Trends Forecast to 2032

19 December 2025125 pages

Choose your research edition.

Industry ResearchEPA & DHA Omega-3 Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal EPA & DHA Omega-3 Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal EPA & DHA Omega-3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EPA & DHA Omega-3 Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal EPA & DHA Omega-3 Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global EPA & DHA Omega-3 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of EPA & DHA Omega-3 include Shandong Yuwang Pharmaceutical, Xinzhou, TASA, Solutex, Skuny, Sinomega, Polaris, Orkla Health and Omega Protein, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global EPA & DHA Omega-3 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The EPA & DHA Omega-3 market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global EPA & DHA Omega-3 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to EPA & DHA Omega-3.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global EPA & DHA Omega-3 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

EPA & DHA Omega-3 Market by Company

Shandong Yuwang Pharmaceutical

Xinzhou

TASA

Solutex

Skuny

Sinomega

Polaris

Orkla Health

Omega Protein

OLVEA Fish Oils

Nippon Suisan Kaisha

Maruha Nichiro Foods

Marine Ingredients

LYSI

Kinomega

KD Pharma

Hofseth BioCare

Golden Omega

GC Rieber

EPAX

DSM

Croda

Bioprocess Algae

BASF

Auqi

Anti-Cancer

EPA & DHA Omega-3 Segment by Type

Marine Animals Source Omega-3

Marine Plant Source Omega-3

EPA & DHA Omega-3 Segment by Application

Pet Foods

Fortified Food and Beverage

Dietary Supplements

Pharmaceuticals

Infant Formula

Others

EPA & DHA Omega-3 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA & DHA Omega-3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EPA & DHA Omega-3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA & DHA Omega-3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of EPA & DHA Omega-3 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of EPA & DHA Omega-3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Marine Animals Source Omega-3 Table 2. Major Company of Marine Plant Source Omega-3 Table 3. Global EPA & DHA Omega-3 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global EPA & DHA Omega-3 Sales by Type (2021-2026) & (K Tons) Table 5. Global EPA & DHA Omega-3 Sales Market Share in Volume by Type (2021-2026) Table 6. Global EPA & DHA Omega-3 Sales by Type (2021-2026) & (US$ Million) Table 7. Global EPA & DHA Omega-3 Sales Market Share in Value by Type (2021-2026) Table 8. Global EPA & DHA Omega-3 Price by Type (2021-2026) & (US$/Ton) Table 9. Global EPA & DHA Omega-3 Sales by Type (2027-2032) & (K Tons) Table 10. Global EPA & DHA Omega-3 Sales Market Share in Volume by Type (2027-2032) Table 11. Global EPA & DHA Omega-3 Sales by Type (2027-2032) & (US$ Million) Table 12. Global EPA & DHA Omega-3 Sales Market Share in Value by Type (2027-2032) Table 13. Global EPA & DHA Omega-3 Price by Type (2027-2032) & (US$/Ton) Table 14. North America EPA & DHA Omega-3 Sales by Type (2021-2026) & (K Tons) Table 15. North America EPA & DHA Omega-3 Sales by Type (2021-2026) & (US$ Million) Table 16. Europe EPA & DHA Omega-3 Sales by Type (2021-2026) & (K Tons) Table 17. Europe EPA & DHA Omega-3 Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific EPA & DHA Omega-3 Sales by Type (2021-2026) & (K Tons) Table 19. Asia-Pacific EPA & DHA Omega-3 Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America EPA & DHA Omega-3 Sales by Type (2021-2026) & (K Tons) Table 21. Latin America EPA & DHA Omega-3 Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa EPA & DHA Omega-3 Sales by Type (2021-2026) & (K Tons) Table 23. Middle East and Africa EPA & DHA Omega-3 Sales by Type (2021-2026) & (US$ Million) Table 24. EPA & DHA Omega-3 Industry Trends Table 25. EPA & DHA Omega-3 Industry Drivers Table 26. EPA & DHA Omega-3 Industry Opportunities and Challenges Table 27. EPA & DHA Omega-3 Industry Restraints Table 28. Global EPA & DHA Omega-3 Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global EPA & DHA Omega-3 Revenue Market Share by Company (2021-2026) Table 30. Global EPA & DHA Omega-3 Sales by Company (2021-2026) & (K Tons) Table 31. Global EPA & DHA Omega-3 Sales Share by Company (2021-2026) Table 32. Global EPA & DHA Omega-3 Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global EPA & DHA Omega-3 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global EPA & DHA Omega-3 Major Company Production Sites and Headquarters Table 35. Global EPA & DHA Omega-3 Company, Product Type & Application Table 36. Global EPA & DHA Omega-3 Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global EPA & DHA Omega-3 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global EPA & DHA Omega-3 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global EPA & DHA Omega-3 Sales by Region (2021-2026) & (K Tons) Table 41. Global EPA & DHA Omega-3 Sales Market Share in Volume by Region (2021-2026) Table 42. Global EPA & DHA Omega-3 Sales by Region (2021-2026) & (US$ Million) Table 43. Global EPA & DHA Omega-3 Sales Market Share in Value by Region (2021-2026) Table 44. Global EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global EPA & DHA Omega-3 Sales by Region (2027-2032) & (K Tons) Table 46. Global EPA & DHA Omega-3 Sales Market Share in Volume by Region (2027-2032) Table 47. Global EPA & DHA Omega-3 Sales by Region (2027-2032) & (US$ Million) Table 48. Global EPA & DHA Omega-3 Sales Market Share in Value by Region (2027-2032) Table 49. Global EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global EPA & DHA Omega-3 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global EPA & DHA Omega-3 Sales by Application (2021-2026) & (K Tons) Table 52. Global EPA & DHA Omega-3 Sales Market Share in Volume by Application (2021-2026) Table 53. Global EPA & DHA Omega-3 Sales by Application (2021-2026) & (US$ Million) Table 54. Global EPA & DHA Omega-3 Sales Market Share in Value by Application (2021-2026) Table 55. Global EPA & DHA Omega-3 Price by Application (2021-2026) & (US$/Ton) Table 56. Global EPA & DHA Omega-3 Sales by Application (2027-2032) & (K Tons) Table 57. Global EPA & DHA Omega-3 Sales Market Share in Volume by Application (2027-2032) Table 58. Global EPA & DHA Omega-3 Sales by Application (2027-2032) & (US$ Million) Table 59. Global EPA & DHA Omega-3 Sales Market Share in Value by Application (2027-2032) Table 60. Global EPA & DHA Omega-3 Price by Application (2027-2032) & (US$/Ton) Table 61. North America EPA & DHA Omega-3 Sales by Application (2021-2026) & (K Tons) Table 62. North America EPA & DHA Omega-3 Sales by Application (2021-2026) & (US$ Million) Table 63. Europe EPA & DHA Omega-3 Sales by Application (2021-2026) & (K Tons) Table 64. Europe EPA & DHA Omega-3 Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific EPA & DHA Omega-3 Sales by Application (2021-2026) & (K Tons) Table 66. Asia-Pacific EPA & DHA Omega-3 Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America EPA & DHA Omega-3 Sales by Application (2021-2026) & (K Tons) Table 68. Latin America EPA & DHA Omega-3 Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa EPA & DHA Omega-3 Sales by Application (2021-2026) & (K Tons) Table 70. Middle East and Africa EPA & DHA Omega-3 Sales by Application (2021-2026) & (US$ Million) Table 71. Shandong Yuwang Pharmaceutical Company Information Table 72. Shandong Yuwang Pharmaceutical Business Overview Table 73. Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Product Portfolio Table 75. Shandong Yuwang Pharmaceutical Recent Development Table 76. Xinzhou Company Information Table 77. Xinzhou Business Overview Table 78. Xinzhou EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Xinzhou EPA & DHA Omega-3 Product Portfolio Table 80. Xinzhou Recent Development Table 81. TASA Company Information Table 82. TASA Business Overview Table 83. TASA EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. TASA EPA & DHA Omega-3 Product Portfolio Table 85. TASA Recent Development Table 86. Solutex Company Information Table 87. Solutex Business Overview Table 88. Solutex EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Solutex EPA & DHA Omega-3 Product Portfolio Table 90. Solutex Recent Development Table 91. Skuny Company Information Table 92. Skuny Business Overview Table 93. Skuny EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Skuny EPA & DHA Omega-3 Product Portfolio Table 95. Skuny Recent Development Table 96. Sinomega Company Information Table 97. Sinomega Business Overview Table 98. Sinomega EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Sinomega EPA & DHA Omega-3 Product Portfolio Table 100. Sinomega Recent Development Table 101. Polaris Company Information Table 102. Polaris Business Overview Table 103. Polaris EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Polaris EPA & DHA Omega-3 Product Portfolio Table 105. Polaris Recent Development Table 106. Orkla Health Company Information Table 107. Orkla Health Business Overview Table 108. Orkla Health EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Orkla Health EPA & DHA Omega-3 Product Portfolio Table 110. Orkla Health Recent Development Table 111. Omega Protein Company Information Table 112. Omega Protein Business Overview Table 113. Omega Protein EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Omega Protein EPA & DHA Omega-3 Product Portfolio Table 115. Omega Protein Recent Development Table 116. OLVEA Fish Oils Company Information Table 117. OLVEA Fish Oils Business Overview Table 118. OLVEA Fish Oils EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. OLVEA Fish Oils EPA & DHA Omega-3 Product Portfolio Table 120. OLVEA Fish Oils Recent Development Table 121. Nippon Suisan Kaisha Company Information Table 122. Nippon Suisan Kaisha Business Overview Table 123. Nippon Suisan Kaisha EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Nippon Suisan Kaisha EPA & DHA Omega-3 Product Portfolio Table 125. Nippon Suisan Kaisha Recent Development Table 126. Maruha Nichiro Foods Company Information Table 127. Maruha Nichiro Foods Business Overview Table 128. Maruha Nichiro Foods EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Maruha Nichiro Foods EPA & DHA Omega-3 Product Portfolio Table 130. Maruha Nichiro Foods Recent Development Table 131. Marine Ingredients Company Information Table 132. Marine Ingredients Business Overview Table 133. Marine Ingredients EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 134. Marine Ingredients EPA & DHA Omega-3 Product Portfolio Table 135. Marine Ingredients Recent Development Table 136. LYSI Company Information Table 137. LYSI Business Overview Table 138. LYSI EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 139. LYSI EPA & DHA Omega-3 Product Portfolio Table 140. LYSI Recent Development Table 141. Kinomega Company Information Table 142. Kinomega Business Overview Table 143. Kinomega EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 144. Kinomega EPA & DHA Omega-3 Product Portfolio Table 145. Kinomega Recent Development Table 146. KD Pharma Company Information Table 147. KD Pharma Business Overview Table 148. KD Pharma EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 149. KD Pharma EPA & DHA Omega-3 Product Portfolio Table 150. KD Pharma Recent Development Table 151. Hofseth BioCare Company Information Table 152. Hofseth BioCare Business Overview Table 153. Hofseth BioCare EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 154. Hofseth BioCare EPA & DHA Omega-3 Product Portfolio Table 155. Hofseth BioCare Recent Development Table 156. Golden Omega Company Information Table 157. Golden Omega Business Overview Table 158. Golden Omega EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 159. Golden Omega EPA & DHA Omega-3 Product Portfolio Table 160. Golden Omega Recent Development Table 161. GC Rieber Company Information Table 162. GC Rieber Business Overview Table 163. GC Rieber EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 164. GC Rieber EPA & DHA Omega-3 Product Portfolio Table 165. GC Rieber Recent Development Table 166. EPAX Company Information Table 167. EPAX Business Overview Table 168. EPAX EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 169. EPAX EPA & DHA Omega-3 Product Portfolio Table 170. EPAX Recent Development Table 171. DSM Company Information Table 172. DSM Business Overview Table 173. DSM EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 174. DSM EPA & DHA Omega-3 Product Portfolio Table 175. DSM Recent Development Table 176. Croda Company Information Table 177. Croda Business Overview Table 178. Croda EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 179. Croda EPA & DHA Omega-3 Product Portfolio Table 180. Croda Recent Development Table 181. Bioprocess Algae Company Information Table 182. Bioprocess Algae Business Overview Table 183. Bioprocess Algae EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 184. Bioprocess Algae EPA & DHA Omega-3 Product Portfolio Table 185. Bioprocess Algae Recent Development Table 186. BASF Company Information Table 187. BASF Business Overview Table 188. BASF EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 189. BASF EPA & DHA Omega-3 Product Portfolio Table 190. BASF Recent Development Table 191. Auqi Company Information Table 192. Auqi Business Overview Table 193. Auqi EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 194. Auqi EPA & DHA Omega-3 Product Portfolio Table 195. Auqi Recent Development Table 196. Anti-Cancer Company Information Table 197. Anti-Cancer Business Overview Table 198. Anti-Cancer EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 199. Anti-Cancer EPA & DHA Omega-3 Product Portfolio Table 200. Anti-Cancer Recent Development Table 201. North America EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 202. North America EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 203. North America EPA & DHA Omega-3 Sales Market Share by Country (2021-2026) Table 204. North America EPA & DHA Omega-3 Sales Forecast by Country (2027-2032) & (K Tons) Table 205. North America EPA & DHA Omega-3 Sales Market Share Forecast by Country (2027-2032) Table 206. North America EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. North America EPA & DHA Omega-3 Market Size by Country (2021-2026) & (US$ Million) Table 208. North America EPA & DHA Omega-3 Market Share by Country (2021-2026) Table 209. North America EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. North America EPA & DHA Omega-3 Market Share Forecast by Country (2027-2032) Table 211. Europe EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 212. Europe EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 213. Europe EPA & DHA Omega-3 Sales Market Share by Country (2021-2026) Table 214. Europe EPA & DHA Omega-3 Sales Forecast by Country (2027-2032) & (K Tons) Table 215. Europe EPA & DHA Omega-3 Sales Market Share Forecast by Country (2027-2032) Table 216. Europe EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Europe EPA & DHA Omega-3 Market Size by Country (2021-2026) & (US$ Million) Table 218. Europe EPA & DHA Omega-3 Market Share by Country (2021-2026) Table 219. Europe EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Europe EPA & DHA Omega-3 Market Share Forecast by Country (2027-2032) Table 221. Asia-Pacific EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 222. Asia-Pacific EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 223. Asia-Pacific EPA & DHA Omega-3 Sales Market Share by Country (2021-2026) Table 224. Asia-Pacific EPA & DHA Omega-3 Sales Forecast by Country (2027-2032) & (K Tons) Table 225. Asia-Pacific EPA & DHA Omega-3 Sales Market Share Forecast by Country (2027-2032) Table 226. Asia-Pacific EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. Asia-Pacific EPA & DHA Omega-3 Market Size by Country (2021-2026) & (US$ Million) Table 228. Asia-Pacific EPA & DHA Omega-3 Market Share by Country (2021-2026) Table 229. Asia-Pacific EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. Asia-Pacific EPA & DHA Omega-3 Market Share Forecast by Country (2027-2032) Table 231. Latin America EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 232. Latin America EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 233. Latin America EPA & DHA Omega-3 Sales Market Share by Country (2021-2026) Table 234. Latin America EPA & DHA Omega-3 Sales Forecast by Country (2027-2032) & (K Tons) Table 235. Latin America EPA & DHA Omega-3 Sales Market Share Forecast by Country (2027-2032) Table 236. Latin America EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 237. Latin America EPA & DHA Omega-3 Market Size by Country (2021-2026) & (US$ Million) Table 238. Latin America EPA & DHA Omega-3 Market Share by Country (2021-2026) Table 239. Latin America EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 240. Latin America EPA & DHA Omega-3 Market Share Forecast by Country (2027-2032) Table 241. Middle East and Africa EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 242. Middle East and Africa EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 243. Middle East and Africa EPA & DHA Omega-3 Sales Market Share by Country (2021-2026) Table 244. Middle East and Africa EPA & DHA Omega-3 Sales Forecast by Country (2027-2032) & (K Tons) Table 245. Middle East and Africa EPA & DHA Omega-3 Sales Market Share Forecast by Country (2027-2032) Table 246. Middle East and Africa EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 247. Middle East and Africa EPA & DHA Omega-3 Market Size by Country (2021-2026) & (US$ Million) Table 248. Middle East and Africa EPA & DHA Omega-3 Market Share by Country (2021-2026) Table 249. Middle East and Africa EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 250. Middle East and Africa EPA & DHA Omega-3 Market Share Forecast by Country (2027-2032) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. EPA & DHA Omega-3 Distributors List Table 254. EPA & DHA Omega-3 Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. EPA & DHA Omega-3 Image Figure 2. Global EPA & DHA Omega-3 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EPA & DHA Omega-3 Market Size (2021-2032) & (US$ Million) Figure 4. Global EPA & DHA Omega-3 Sales (2021-2032) & (K Tons) Figure 5. Marine Animals Source Omega-3 Image Figure 6. Global Marine Animals Source Omega-3 Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Marine Plant Source Omega-3 Image Figure 8. Global Marine Plant Source Omega-3 Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Global EPA & DHA Omega-3 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global EPA & DHA Omega-3 Market Share by Type 2025 VS 2032 Figure 11. North America EPA & DHA Omega-3 Sales Market Share in Volume by Type in 2025 Figure 12. North America EPA & DHA Omega-3 Sales Market Share in Value by Type in 2025 Figure 13. Europe EPA & DHA Omega-3 Sales Market Share in Volume by Type in 2025 Figure 14. Europe EPA & DHA Omega-3 Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific EPA & DHA Omega-3 Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific EPA & DHA Omega-3 Sales Market Share in Value by Type in 2025 Figure 17. Latin America EPA & DHA Omega-3 Sales Market Share in Volume by Type in 2025 Figure 18. Latin America EPA & DHA Omega-3 Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa EPA & DHA Omega-3 Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa EPA & DHA Omega-3 Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 EPA & DHA Omega-3 Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pet Foods Image Figure 24. Global Pet Foods Sales YoY Growth (2021-2032) & (K Tons) Figure 25. Fortified Food and Beverage Image Figure 26. Global Fortified Food and Beverage Sales YoY Growth (2021-2032) & (K Tons) Figure 27. Dietary Supplements Image Figure 28. Global Dietary Supplements Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Pharmaceuticals Image Figure 30. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (K Tons) Figure 31. Infant Formula Image Figure 32. Global Infant Formula Sales YoY Growth (2021-2032) & (K Tons) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Tons) Figure 35. Global EPA & DHA Omega-3 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global EPA & DHA Omega-3 Market Share by Application 2025 VS 2032 Figure 37. North America EPA & DHA Omega-3 Sales Market Share in Volume by Application in 2025 Figure 38. North America EPA & DHA Omega-3 Sales Market Share in Value by Application in 2025 Figure 39. Europe EPA & DHA Omega-3 Sales Market Share in Volume by Application in 2025 Figure 40. Europe EPA & DHA Omega-3 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific EPA & DHA Omega-3 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific EPA & DHA Omega-3 Sales Market Share in Value by Application in 2025 Figure 43. Latin America EPA & DHA Omega-3 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America EPA & DHA Omega-3 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa EPA & DHA Omega-3 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa EPA & DHA Omega-3 Sales Market Share in Value by Application in 2025 Figure 47. North America EPA & DHA Omega-3 Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 48. North America EPA & DHA Omega-3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America EPA & DHA Omega-3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe EPA & DHA Omega-3 Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 52. Europe EPA & DHA Omega-3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe EPA & DHA Omega-3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific EPA & DHA Omega-3 Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 56. Asia-Pacific EPA & DHA Omega-3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific EPA & DHA Omega-3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America EPA & DHA Omega-3 Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 60. Latin America EPA & DHA Omega-3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America EPA & DHA Omega-3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa EPA & DHA Omega-3 Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 64. Middle East and Africa EPA & DHA Omega-3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa EPA & DHA Omega-3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. EPA & DHA Omega-3 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. EPA & DHA Omega-3 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Marine Animals Source Omega-3
  • Marine Plant Source Omega-3
Applications
  • Pet Foods
  • Fortified Food and Beverage
  • Dietary Supplements
  • Pharmaceuticals
  • Infant Formula
  • Others
Companies covered
  • Shandong Yuwang Pharmaceutical
  • Xinzhou
  • TASA
  • Solutex
  • Skuny
  • Sinomega
  • Polaris
  • Orkla Health
  • Omega Protein
  • OLVEA Fish Oils
  • Nippon Suisan Kaisha
  • Maruha Nichiro Foods
  • Marine Ingredients
  • LYSI
  • Kinomega
  • KD Pharma
  • Hofseth BioCare
  • Golden Omega
  • GC Rieber
  • EPAX
  • DSM
  • Croda
  • Bioprocess Algae
  • BASF
  • Auqi
  • Anti-Cancer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EPA & DHA Omega-3 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global EPA & DHA Omega-3 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 EPA & DHA Omega-3 Market by Type
  6. 1.3.1 Marine Animals Source Omega-3
  7. 1.3.2 Marine Plant Source Omega-3
  8. 1.4 Global EPA & DHA Omega-3 Market Size by Type
  9. 1.4.1 Global EPA & DHA Omega-3 Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global EPA & DHA Omega-3 Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global EPA & DHA Omega-3 Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America EPA & DHA Omega-3 Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe EPA & DHA Omega-3 Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific EPA & DHA Omega-3 Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America EPA & DHA Omega-3 Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa EPA & DHA Omega-3 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 EPA & DHA Omega-3 Industry Trends
  2. 2.2 EPA & DHA Omega-3 Industry Drivers
  3. 2.3 EPA & DHA Omega-3 Industry Opportunities and Challenges
  4. 2.4 EPA & DHA Omega-3 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by EPA & DHA Omega-3 Revenue (2021-2026)
  2. 3.2 Global Top Players by EPA & DHA Omega-3 Sales (2021-2026)
  3. 3.3 Global Top Players by EPA & DHA Omega-3 Price (2021-2026)
  4. 3.4 Global EPA & DHA Omega-3 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global EPA & DHA Omega-3 Major Company Production Sites & Headquarters
  6. 3.6 Global EPA & DHA Omega-3 Company, Product Type & Application
  7. 3.7 Global EPA & DHA Omega-3 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global EPA & DHA Omega-3 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 EPA & DHA Omega-3 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 EPA & DHA Omega-3 Tier 1, Tier 2, and Tier 3
4 EPA & DHA Omega-3 Regional Status and Outlook
  1. 4.1 Global EPA & DHA Omega-3 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global EPA & DHA Omega-3 Historic Market Size by Region
  3. 4.2.1 Global EPA & DHA Omega-3 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global EPA & DHA Omega-3 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global EPA & DHA Omega-3 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global EPA & DHA Omega-3 Forecasted Market Size by Region
  7. 4.3.1 Global EPA & DHA Omega-3 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global EPA & DHA Omega-3 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global EPA & DHA Omega-3 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 EPA & DHA Omega-3 by Application
  1. 5.1 EPA & DHA Omega-3 Market by Application
  2. 5.1.1 Pet Foods
  3. 5.1.2 Fortified Food and Beverage
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Pharmaceuticals
  6. 5.1.5 Infant Formula
  7. 5.1.6 Others
  8. 5.2 Global EPA & DHA Omega-3 Market Size by Application
  9. 5.2.1 Global EPA & DHA Omega-3 Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global EPA & DHA Omega-3 Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global EPA & DHA Omega-3 Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America EPA & DHA Omega-3 Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe EPA & DHA Omega-3 Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific EPA & DHA Omega-3 Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America EPA & DHA Omega-3 Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa EPA & DHA Omega-3 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shandong Yuwang Pharmaceutical
  2. 6.1.1 Shandong Yuwang Pharmaceutical Company Information
  3. 6.1.2 Shandong Yuwang Pharmaceutical Business Overview
  4. 6.1.3 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Product Portfolio
  6. 6.1.5 Shandong Yuwang Pharmaceutical Recent Developments
  7. 6.2 Xinzhou
  8. 6.2.1 Xinzhou Company Information
  9. 6.2.2 Xinzhou Business Overview
  10. 6.2.3 Xinzhou EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Xinzhou EPA & DHA Omega-3 Product Portfolio
  12. 6.2.5 Xinzhou Recent Developments
  13. 6.3 TASA
  14. 6.3.1 TASA Company Information
  15. 6.3.2 TASA Business Overview
  16. 6.3.3 TASA EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TASA EPA & DHA Omega-3 Product Portfolio
  18. 6.3.5 TASA Recent Developments
  19. 6.4 Solutex
  20. 6.4.1 Solutex Company Information
  21. 6.4.2 Solutex Business Overview
  22. 6.4.3 Solutex EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Solutex EPA & DHA Omega-3 Product Portfolio
  24. 6.4.5 Solutex Recent Developments
  25. 6.5 Skuny
  26. 6.5.1 Skuny Company Information
  27. 6.5.2 Skuny Business Overview
  28. 6.5.3 Skuny EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Skuny EPA & DHA Omega-3 Product Portfolio
  30. 6.5.5 Skuny Recent Developments
  31. 6.6 Sinomega
  32. 6.6.1 Sinomega Company Information
  33. 6.6.2 Sinomega Business Overview
  34. 6.6.3 Sinomega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sinomega EPA & DHA Omega-3 Product Portfolio
  36. 6.6.5 Sinomega Recent Developments
  37. 6.7 Polaris
  38. 6.7.1 Polaris Company Information
  39. 6.7.2 Polaris Business Overview
  40. 6.7.3 Polaris EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Polaris EPA & DHA Omega-3 Product Portfolio
  42. 6.7.5 Polaris Recent Developments
  43. 6.8 Orkla Health
  44. 6.8.1 Orkla Health Company Information
  45. 6.8.2 Orkla Health Business Overview
  46. 6.8.3 Orkla Health EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Orkla Health EPA & DHA Omega-3 Product Portfolio
  48. 6.8.5 Orkla Health Recent Developments
  49. 6.9 Omega Protein
  50. 6.9.1 Omega Protein Company Information
  51. 6.9.2 Omega Protein Business Overview
  52. 6.9.3 Omega Protein EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Omega Protein EPA & DHA Omega-3 Product Portfolio
  54. 6.9.5 Omega Protein Recent Developments
  55. 6.10 OLVEA Fish Oils
  56. 6.10.1 OLVEA Fish Oils Company Information
  57. 6.10.2 OLVEA Fish Oils Business Overview
  58. 6.10.3 OLVEA Fish Oils EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 OLVEA Fish Oils EPA & DHA Omega-3 Product Portfolio
  60. 6.10.5 OLVEA Fish Oils Recent Developments
  61. 6.11 Nippon Suisan Kaisha
  62. 6.11.1 Nippon Suisan Kaisha Company Information
  63. 6.11.2 Nippon Suisan Kaisha Business Overview
  64. 6.11.3 Nippon Suisan Kaisha EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Nippon Suisan Kaisha EPA & DHA Omega-3 Product Portfolio
  66. 6.11.5 Nippon Suisan Kaisha Recent Developments
  67. 6.12 Maruha Nichiro Foods
  68. 6.12.1 Maruha Nichiro Foods Company Information
  69. 6.12.2 Maruha Nichiro Foods Business Overview
  70. 6.12.3 Maruha Nichiro Foods EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Maruha Nichiro Foods EPA & DHA Omega-3 Product Portfolio
  72. 6.12.5 Maruha Nichiro Foods Recent Developments
  73. 6.13 Marine Ingredients
  74. 6.13.1 Marine Ingredients Company Information
  75. 6.13.2 Marine Ingredients Business Overview
  76. 6.13.3 Marine Ingredients EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Marine Ingredients EPA & DHA Omega-3 Product Portfolio
  78. 6.13.5 Marine Ingredients Recent Developments
  79. 6.14 LYSI
  80. 6.14.1 LYSI Company Information
  81. 6.14.2 LYSI Business Overview
  82. 6.14.3 LYSI EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 LYSI EPA & DHA Omega-3 Product Portfolio
  84. 6.14.5 LYSI Recent Developments
  85. 6.15 Kinomega
  86. 6.15.1 Kinomega Company Information
  87. 6.15.2 Kinomega Business Overview
  88. 6.15.3 Kinomega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Kinomega EPA & DHA Omega-3 Product Portfolio
  90. 6.15.5 Kinomega Recent Developments
  91. 6.16 KD Pharma
  92. 6.16.1 KD Pharma Company Information
  93. 6.16.2 KD Pharma Business Overview
  94. 6.16.3 KD Pharma EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 KD Pharma EPA & DHA Omega-3 Product Portfolio
  96. 6.16.5 KD Pharma Recent Developments
  97. 6.17 Hofseth BioCare
  98. 6.17.1 Hofseth BioCare Company Information
  99. 6.17.2 Hofseth BioCare Business Overview
  100. 6.17.3 Hofseth BioCare EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Hofseth BioCare EPA & DHA Omega-3 Product Portfolio
  102. 6.17.5 Hofseth BioCare Recent Developments
  103. 6.18 Golden Omega
  104. 6.18.1 Golden Omega Company Information
  105. 6.18.2 Golden Omega Business Overview
  106. 6.18.3 Golden Omega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Golden Omega EPA & DHA Omega-3 Product Portfolio
  108. 6.18.5 Golden Omega Recent Developments
  109. 6.19 GC Rieber
  110. 6.19.1 GC Rieber Company Information
  111. 6.19.2 GC Rieber Business Overview
  112. 6.19.3 GC Rieber EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 GC Rieber EPA & DHA Omega-3 Product Portfolio
  114. 6.19.5 GC Rieber Recent Developments
  115. 6.20 EPAX
  116. 6.20.1 EPAX Company Information
  117. 6.20.2 EPAX Business Overview
  118. 6.20.3 EPAX EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 EPAX EPA & DHA Omega-3 Product Portfolio
  120. 6.20.5 EPAX Recent Developments
  121. 6.21 DSM
  122. 6.21.1 DSM Company Information
  123. 6.21.2 DSM Business Overview
  124. 6.21.3 DSM EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 DSM EPA & DHA Omega-3 Product Portfolio
  126. 6.21.5 DSM Recent Developments
  127. 6.22 Croda
  128. 6.22.1 Croda Company Information
  129. 6.22.2 Croda Business Overview
  130. 6.22.3 Croda EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Croda EPA & DHA Omega-3 Product Portfolio
  132. 6.22.5 Croda Recent Developments
  133. 6.23 Bioprocess Algae
  134. 6.23.1 Bioprocess Algae Company Information
  135. 6.23.2 Bioprocess Algae Business Overview
  136. 6.23.3 Bioprocess Algae EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Bioprocess Algae EPA & DHA Omega-3 Product Portfolio
  138. 6.23.5 Bioprocess Algae Recent Developments
  139. 6.24 BASF
  140. 6.24.1 BASF Company Information
  141. 6.24.2 BASF Business Overview
  142. 6.24.3 BASF EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 BASF EPA & DHA Omega-3 Product Portfolio
  144. 6.24.5 BASF Recent Developments
  145. 6.25 Auqi
  146. 6.25.1 Auqi Company Information
  147. 6.25.2 Auqi Business Overview
  148. 6.25.3 Auqi EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Auqi EPA & DHA Omega-3 Product Portfolio
  150. 6.25.5 Auqi Recent Developments
  151. 6.26 Anti-Cancer
  152. 6.26.1 Anti-Cancer Company Information
  153. 6.26.2 Anti-Cancer Business Overview
  154. 6.26.3 Anti-Cancer EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Anti-Cancer EPA & DHA Omega-3 Product Portfolio
  156. 6.26.5 Anti-Cancer Recent Developments
7 North America by Country
  1. 7.1 North America EPA & DHA Omega-3 Sales by Country
  2. 7.1.1 North America EPA & DHA Omega-3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America EPA & DHA Omega-3 Sales by Country (2021-2026)
  4. 7.1.3 North America EPA & DHA Omega-3 Sales Forecast by Country (2027-2032)
  5. 7.2 North America EPA & DHA Omega-3 Market Size by Country
  6. 7.2.1 North America EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America EPA & DHA Omega-3 Market Size by Country (2021-2026)
  8. 7.2.3 North America EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe EPA & DHA Omega-3 Sales by Country
  2. 8.1.1 Europe EPA & DHA Omega-3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe EPA & DHA Omega-3 Sales by Country (2021-2026)
  4. 8.1.3 Europe EPA & DHA Omega-3 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe EPA & DHA Omega-3 Market Size by Country
  6. 8.2.1 Europe EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe EPA & DHA Omega-3 Market Size by Country (2021-2026)
  8. 8.2.3 Europe EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific EPA & DHA Omega-3 Sales by Country
  2. 9.1.1 Asia-Pacific EPA & DHA Omega-3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific EPA & DHA Omega-3 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific EPA & DHA Omega-3 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific EPA & DHA Omega-3 Market Size by Country
  6. 9.2.1 Asia-Pacific EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific EPA & DHA Omega-3 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America EPA & DHA Omega-3 Sales by Country
  2. 10.1.1 South America EPA & DHA Omega-3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America EPA & DHA Omega-3 Sales by Country (2021-2026)
  4. 10.1.3 South America EPA & DHA Omega-3 Sales Forecast by Country (2027-2032)
  5. 10.2 South America EPA & DHA Omega-3 Market Size by Country
  6. 10.2.1 South America EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America EPA & DHA Omega-3 Market Size by Country (2021-2026)
  8. 10.2.3 South America EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa EPA & DHA Omega-3 Sales by Country
  2. 11.1.1 Middle East and Africa EPA & DHA Omega-3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa EPA & DHA Omega-3 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa EPA & DHA Omega-3 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa EPA & DHA Omega-3 Market Size by Country
  6. 11.2.1 Middle East and Africa EPA & DHA Omega-3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa EPA & DHA Omega-3 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa EPA & DHA Omega-3 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 EPA & DHA Omega-3 Value Chain Analysis
  2. 12.1.1 EPA & DHA Omega-3 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 EPA & DHA Omega-3 Production Mode & Process
  7. 12.2 EPA & DHA Omega-3 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 EPA & DHA Omega-3 Distributors
  10. 12.2.3 EPA & DHA Omega-3 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst